Measurement of ESAT6-induced IFNγ responses adjunct with CXCL9 increases the rate of diagnosis of active tuberculosis in an endemic region

by Zahra Hasan, Nisar Rao, Naseem Salahuddin, Mussarat Ashraf, Muniba Islam, Bushra Jamil
Published 2013-01-01

Increased Osteoblastic Cxcl9 Contributes to the Uncoupled Bone Formation and Resorption in Postmenopausal Osteoporosis

by Liu Z, Liang W, Kang D, Chen Q, Ouyang Z, Yan H, Huang B, Jin D, Chen Y, Li Q
Published 2020-07-01

CXCL9 as a Prognostic Inflammatory Marker in Early-Stage Lung Adenocarcinoma Patients

by Yanwei Zhang, Beibei Sun, Minjuan Hu, Yuqing Lou, Jun Lu, Xueyan Zhang, Huimin Wang, Jialin Qian, Tianqing Chu, Baohui Han
Published 2020-06-01

CXCL9: evidence and contradictions for its role in tumor progression

by Qiang Ding, Panpan Lu, Yujia Xia, Shuping Ding, Yuhui Fan, Xin Li, Ping Han, Jingmei Liu, Dean Tian, Mei Liu
Published 2016-11-01

Rapid Biolayer Interferometry Measurements of Urinary CXCL9 to Detect Cellular Infiltrates Noninvasively After Kidney Transplantation

by Ilaria Gandolfini, Cynthia Harris, Michael Abecassis, Lisa Anderson, Oriol Bestard, Giorgia Comai, Paolo Cravedi, Elena Cremaschi, J. Andrew Duty, Sander Florman, John Friedewald, Gaetano La Manna, Umberto Maggiore, Thomas Moran, Giovanni Piotti, Carolina Purroy, Marta Jarque, Vinay Nair, Ron Shapiro, Jessica Reid-Adam, Peter S. Heeger
Published 2017-11-01

CXCL9-Derived Peptides Differentially Inhibit Neutrophil Migration In Vivo through Interference with Glycosaminoglycan Interactions

by Vincent Vanheule, Daiane Boff, Daiane Boff, Anneleen Mortier, Rik Janssens, Björn Petri, Elzbieta Kolaczkowska, Elzbieta Kolaczkowska, Paul Kubes, Nele Berghmans, Sofie Struyf, Andreas J. Kungl, Mauro Martins Teixeira, Flavio Almeida Amaral, Paul Proost
Published 2017-05-01

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer

by Yuan-ke Liang, Yuan-ke Liang, Ze-kun- Deng, Mu-tong Chen, Si-qi Qiu, Si-qi Qiu, Ying-sheng Xiao, Ying-sheng Xiao, Yu-zhu Qi, Yu-zhu Qi, Qin Xie, Zheng-hao Wang, Shi-cheng Jia, De Zeng, De Zeng, Hao-yu Lin, Hao-yu Lin
Published 2021-08-01

CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond

by Nathan Karin
Published 2020-05-01

CXCL9, a promising biomarker in the diagnosis of chronic Q fever

by Anne F. M. Jansen, Teske Schoffelen, Julien Textoris, Jean-Louis Mege, Marrigje Nabuurs-Franssen, Ruud P. H. Raijmakers, Mihai G. Netea, Leo A. B. Joosten, Chantal P. Bleeker-Rovers, Marcel van Deuren
Published 2017-08-01

Potential Effects of CXCL9 and CCL20 on Cardiac Fibrosis in Patients with Myocardial Infarction and Isoproterenol-Treated Rats

by Chao-Feng Lin, Chih-Jou Su, Jia-Hong Liu, Shui-Tien Chen, Han-Li Huang, Shiow-Lin Pan
Published 2019-05-01

Estudo da expressão de genes relacionados à resposta inflamatória e autoimune em lesões de líquen plano oral do tipo reticular por meio de PCR-array

by Anna Torrezani
Published 2014

Estudo da expressão de genes relacionados à resposta inflamatória e autoimune em lesões de líquen plano oral do tipo reticular por meio de PCR-array

by Torrezani, Anna
Published 2014

The role of CXCR3 and its ligands expression in Brucellar spondylitis

by Xin Hu, Xiaoqian Shang, Liang Wang, Jiahui Fan, Yue Wang, Jie Lv, Shaxika Nazierhan, Hao Wang, Jing Wang, Xiumin Ma
Published 2020-11-01

Prognosis of ovarian cancer is associated with effector memory CD8+ T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells

by Sonja Lieber, Silke Reinartz, Hartmann Raifer, Florian Finkernagel, Tobias Dreyer, Holger Bronger, Julia M. Jansen, Uwe Wagner, Thomas Worzfeld, Rolf Müller, Magdalena Huber
Published 2018-05-01

IL-17 inhibits CXCL9/10-mediated recruitment of CD8+ cytotoxic T cells and regulatory T cells to colorectal tumors

by Ju Chen, Xiaoyang Ye, Elise Pitmon, Mengqian Lu, Jun Wan, Evan R. Jellison, Adam J. Adler, Anthony T. Vella, Kepeng Wang
Published 2019-11-01

The Effect of Annona Muricata Leaves Towards Blood Levels of Cxcl9 and Lymphoblast (Study in Cerebral Malaria Phase of Swiss Mice)

by Mohamed M.Y. Gadalla, Edi Dharmana, Kiss Jamiatun, Budi Laksono
Published 2015-09-01

CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma—Diagnostic, Therapeutic, and Prognostic Relevance

by Ilias Masouris, Kirsi Manz, Markus Pfirrmann, Martin Dreyling, Barbara Angele, Andreas Straube, Sigrid Langer, Marion Huber, Uwe Koedel, Louisa Von Baumgarten, Louisa Von Baumgarten
Published 2021-03-01

Chronic Obstructive Pulmonary Disease Patients Have Increased Levels of Plasma Inflammatory Mediators Reported Upregulated in Severe COVID-19

by Nathalie Acevedo, Jose Miguel Escamilla-Gil, Héctor Espinoza, Ronald Regino, Jonathan Ramírez, Lucila Florez de Arco, Rodolfo Dennis, Carlos A. Torres-Duque, Carlos A. Torres-Duque, Luis Caraballo
Published 2021-07-01

CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer

by Chenlu Zhang, Zhi Li, Ling Xu, Xiaofang Che, Ti Wen, Yibo Fan, Ce Li, Shuo Wang, Yu Cheng, Xiaoxun Wang, Xiujuan Qu, Yunpeng Liu
Published 2018-04-01